BRCA1 and breast carcinoma: The opposite was reported by Kim et al. who showed that a high plasma folate (>24.4 ng/mL) concentration may be associated with an increased risk of breast cancer according to a prospective study in 164 BRCA1 and Breast Cancer gene 2 (BRCA2) mutation carriers [25,46].